SLC5A2 and diabetes mellitus: Therefore, we conducted a systematic review and meta-analysis of SGLT2 inhibitors in randomized controlled trials (RCTs) to assess whether SGLT2 inhibitors could lead to weight loss in adults with overweight or obesity but not diabetes.